DASGIP claims itself to know the users of the DASGIP products and their specific requirements for various applications very well. Here, DASGIP team would like to introduce to some of our valued customers - or rather: let them introduce themselves by answering five questions - about themselves, their employer and current challenges for the market they work for.
The Bioprocess International Conference and Exhibition is one of the key events for a comprehensive update on operational strategies, technologies, regulatory changes, manufacturing production and process development.
Improved productivity is critical to the development of highly efficient production processes for biopharmaceutical proteins. Despite the apparent value of feedback control systems in the biopharmaceutical industry there are only a few successful demonstrations.
DASGIP announces that its own Larry West will be giving a presentation titled “The Role of ‘Context’ in Converting Process Data into Process Information” at Interphex, New York.
The membership of Celerion’s Belfast facility within the UK Respiratory Therapeutic Capability Cluster enables faster access to patient populations, specialists and techniques in Phase I & IIa studies. Clients benefit from faster access to data that expedites decision making and speeds up the path to clinical Proof-of-Concept.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that Glen de Vries, president, and Bruce Dalziel, chief financial officer, will present at the 13th Annual Needham Growth Conference at 8:40 a.m. ET on January 13, 2011 in New York, NY.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that PharPoint Research, Inc., a North Carolina-based drug development service company, has joined Medidata’s ASPire to Win® channel partner program, bringing the program’s partner count to 30 organizations. With this partnership, PharPoint will be able to offer the Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) solution to its clinical research customers.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today extended the Grants Manager® web-based budgeting application with a new Contracting module, enabling sites and sponsors to negotiate clinical trial site budgets directly online, eliminating the burden of managing hundreds of email messages and reducing budgeting cycle times. Trial managers will also be able to monitor site negotiation status by study, site or across the portfolio in real-time, bringing unprecedented visibility to the process of site recruitment.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that Chugai Pharmaceutical Co., Ltd., a member of the Roche Group and one of Japan’s leading pharmaceutical companies, has selected Medidata Rave® as the standard electronic data capture (EDC) and clinical data management (CDM) platform for its clinical trials. Chugai intends to use Medidata Rave to support all studies conducted during the multiyear contract term, from Phase I–IV.
Randox Pharma Services offers a comprehensive range of technologies and solutions, allowing Pharma Research and Development to become more efficient, cost effective and safer.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.